Literature DB >> 33759960

COULD THE INTESTINAL EPITHELIAL ALTERATIONS PROMOTED BY ROUX-EN-Y GASTRIC BYPASS EXPLAIN HIGHER TENDENCY FOR COLONIC DISEASES IN BARIATRIC PATIENTS?

Eduardo Wendler1, Osvaldo Malafaia1, Bruno Luiz Ariede1, Jurandir Marcondes Ribas-Filho1, Nicolau Gregori Czeczko1, Paulo Afonso Nunes Nassif1.   

Abstract

BACKGROUND: Ki-67 in ascending colon: A) experiment and B) control. Intestinal diversions have revolutionized the treatment of morbid obesity due to its viability and sustained response. However, experimental studies suggest, after these derivations, a higher risk of colon cancer. AIM: To analyze the histological and immunohistological changes that the jejunojejunal shunt can produce in the jejunum, ileum and ascending colon.
METHOD: Twenty-four male Wistar rats were randomly divided into two groups, control (n=12) and experiment (n=12) and subdivided into groups of four. Nine weeks after the jejunojejunal shunt, segmental resection of the excluded jejunum, terminal ileum and ascending colon was performed. Histological analysis focused on the thickness of the mucosa, height of the villi, depth of the crypts and immunohistochemistry in the expression of Ki-67 and p53.
RESULTS: Significant differences were found between the experiment and control groups in relation to the thickness of the mucosa in the jejunum (p=0.011), in the ileum (p<0.001) and in the colon (p=0.027). There was also a significant difference in relation to the height of the villus in the ileum (p<0.001) and the depth of the crypts in the jejunum (p0.001). The results indicated that there is a significant difference between the groups regarding the expression of Ki-67 in the colon (p<0.001). No significant differences were found between the groups regarding the expression of Ki-67 in the jejunum and ileum. In the P53 evaluation, negative nuclear staining was found in all cases.
CONCLUSION: The jejunojejunal deviation performed in the Roux-in-Y gastrojejunal bypass, predispose epithelial proliferative effects, causing an increase in the thickness of the mucosa, height of the villi and depth of the crypts of the jejunum, ileum and ascending colon.

Entities:  

Year:  2021        PMID: 33759960      PMCID: PMC7983526          DOI: 10.1590/0102-672020200004e1570

Source DB:  PubMed          Journal:  Arq Bras Cir Dig        ISSN: 0102-6720


  36 in total

1.  The prognostic value of cell proliferation in colorectal adenomas assessed with tritiated thymidine and anti-proliferating cell nuclear antigen.

Authors:  G Ottaviani; A M Lavezzi; F De Ruberto; G Fichera; L Matturri
Journal:  Cancer Detect Prev       Date:  1999

Review 2.  Colorectal cell kinetics.

Authors:  R Gilliland; K E Williamson; R H Wilson; N H Anderson; P W Hamilton
Journal:  Br J Surg       Date:  1996-06       Impact factor: 6.939

3.  Gastric bypass model in the obese rat to study metabolic mechanisms of weight loss.

Authors:  Y Xu; K Ohinata; M M Meguid; W Marx; T Tada; C Chen; R Quinn; A Inui
Journal:  J Surg Res       Date:  2002-09       Impact factor: 2.192

4.  The effect of lithocholic acid on proliferation and apoptosis during the early stages of colon carcinogenesis: differential effect on apoptosis in the presence of a colon carcinogen.

Authors:  V Kozoni; G Tsioulias; S Shiff; B Rigas
Journal:  Carcinogenesis       Date:  2000-05       Impact factor: 4.944

Review 5.  Obesity and colorectal cancer.

Authors:  Marc Bardou; Alan N Barkun; Myriam Martel
Journal:  Gut       Date:  2013-03-12       Impact factor: 23.059

6.  Early proliferative activity: its occurrence in the crypts of small bowel and colon after partial small-bowel resection.

Authors:  M D Tilson; E M Livstone
Journal:  Arch Surg       Date:  1980-12

7.  Increased colorectal epithelial cell proliferation and crypt fission associated with obesity and roux-en-Y gastric bypass.

Authors:  Anita Sainsbury; Robert A Goodlad; Sarah L Perry; Stephen G Pollard; Gerard G Robins; Mark A Hull
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-06       Impact factor: 4.254

8.  Colorectal cancer risk after jejunoileal bypass: dysplasia and DNA content in longtime follow-up of patients operated on for morbid obesity.

Authors:  A Sylvan; B Sjölund; K G Janunger; J Rutegård; R Stenling; G Roos
Journal:  Dis Colon Rectum       Date:  1992-03       Impact factor: 4.585

9.  Rectal epithelial cell mitosis and expression of macrophage migration inhibitory factor are increased 3 years after Roux-en-Y gastric bypass (RYGB) for morbid obesity: implications for long-term neoplastic risk following RYGB.

Authors:  Prashant Kant; Anita Sainsbury; Karen R Reed; Stephen G Pollard; Nigel Scott; Alan R Clarke; P Louise Coletta; Mark A Hull
Journal:  Gut       Date:  2011-02-08       Impact factor: 23.059

10.  Biomarkers of Colorectal Cancer Risk Decrease 6 months After Roux-en-Y Gastric Bypass Surgery.

Authors:  Sorena Afshar; Fiona Malcomson; Seamus B Kelly; Keith Seymour; Sean Woodcock; John C Mathers
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

View more
  1 in total

1.  SHORTEN PREOPERATIVE FASTING AND INTRODUCING EARLY EATING ASSISTANCE IN RECOVERY AFTER GASTROJEJUNAL BYPASS?

Authors:  Eduardo Wendler; Paulo Afonso Nunes Nassif; Osvaldo Malafaia; Jose Luzardo Brites Neto; José Guilherme Agner Ribeiro; Laura Brandão DE Proença; Maria Eduarda Mattos; Bruno Luiz Ariede
Journal:  Arq Bras Cir Dig       Date:  2022-01-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.